Mice with elevated GPx-1 expression exhibit a T2D-like phenotype characterized by obesity, hyperglycemia, hyperlipidemia, hyperinsulinemia, insulin resistance, increased pancreatic β-cell mass, glucose-stimulated insulin secretion, elevated plasma leptin levels, and hepatic lipogenesis (39). Here, GPX1 is linked to Hyperinsulinemia.